• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Tissue Microarray Market Analysis

    ID: MRFR/LS/0706-CR
    186 Pages
    Rahul Gotadki
    July 2019

    Tissue Microarray Market Research Report Information by Procedure (Immunohistochemistry, Fluorescent In-Situ Hybridization and Frozen Tissue Array), Technology (DNA Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting and Western Blotting), Application (Oncology, Gene Expression Profiling, SNP Detection, Double-Stranded B-DNA Microarrays, Comparative Genomi...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Tissue Microarray Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License

    Market Analysis

    In-depth Analysis of Tissue Microarray Market Industry Landscape

    The market is seeing a surge in popularity because of the developing emphasis on customized medication. Tissue microarrays assume an urgent part in this change in outlook by empowering the examination of different tissue tests at the same time, working with more designated and powerful treatment methodologies. Progressing improvements in molecular biology techniques contribute fundamentally to the elements of the Tissue Microarray Market. As specialists and clinicians look for additional comprehensive experiences into diseases at the molecular level, the utilization of tissue microarrays becomes indispensable for high-throughput examination of biomarkers and genetic diversities. The market is transcendently impacted by the field of disease research. Tissue microarrays smooth out the investigation of cancer tissues, permitting scientists to effectively concentrate on huge companions. As disease remains a critical worldwide wellbeing concern, the interest for tissue microarrays for oncology research keeps on developing. Mechanization is a critical driver in the market elements, improving the effectiveness and versatility of tissue microarray examination. High-throughput abilities empower the simultaneous assessment of various tissue tests, diminishing examination time and further developing exploration efficiency. The mix of artificial intelligence into tissue microarray examination is changing the market. AI algorithms work with the translation of overwhelming information created from tissue microarrays, furnishing analysts with additional exact and quick pieces of knowledge, subsequently speeding up the speed of disclosure. While oncology research remains a point of convergence, the market is venturing into other clinical fields, like neuroscience, infectious diseases, and immune system problems. This expansion expands the market's degree and offers new open doors for advancement and growth.

    Market Summary

    The Global Tissue Microarray Market is projected to grow from 12.3 USD Billion in 2024 to 35.3 USD Billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    Tissue Microarray Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 10.07% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 35.3 USD Billion, indicating substantial expansion.
    • In 2024, the market is valued at 12.3 USD Billion, laying a strong foundation for future growth.
    • Growing adoption of tissue microarray technology due to increasing demand for personalized medicine is a major market driver.

    Market Size & Forecast

    2024 Market Size 12.3 (USD Billion)
    2035 Market Size 35.3 (USD Billion)
    CAGR (2025-2035) 10.07%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    Agilent Technologies, Illumina, Inc., Protein Biotechnologies Inc., Asterand Bioscience, Pantomics Inc., Applied Microarrays, Arrayit, Phalanx Biotech, QIAGEN, Takara Bio, Perkin Elmer, Merck Sharp & Dohme Corp.

    Market Trends

    The ongoing advancements in tissue microarray technology are poised to enhance diagnostic accuracy and facilitate personalized medicine, thereby transforming the landscape of pathology and oncology.

    National Institutes of Health (NIH)

    Tissue Microarray Market Market Drivers

    Market Growth Projections

    The Global Tissue Microarray Market Industry is on a trajectory of substantial growth, with projections indicating an increase from 12.3 USD Billion in 2024 to 35.3 USD Billion by 2035. This growth reflects a compound annual growth rate (CAGR) of 10.07% from 2025 to 2035. Various factors contribute to this upward trend, including rising demand for personalized medicine, technological advancements, and increasing applications in drug development. The market's expansion is indicative of the growing recognition of tissue microarrays as essential tools in research and diagnostics, highlighting their potential to revolutionize the healthcare landscape.

    Rising Demand for Personalized Medicine

    The Global Tissue Microarray Market Industry experiences a notable surge in demand for personalized medicine, driven by advancements in genomics and molecular biology. As healthcare shifts towards tailored treatments, tissue microarrays facilitate the analysis of multiple tissue samples simultaneously, enhancing diagnostic accuracy. This trend is underscored by the projected market growth from 12.3 USD Billion in 2024 to 35.3 USD Billion by 2035, indicating a robust compound annual growth rate (CAGR) of 10.07% from 2025 to 2035. The ability to identify specific biomarkers through tissue microarrays plays a crucial role in developing targeted therapies, thereby propelling the industry forward.

    Supportive Government Initiatives and Funding

    Government initiatives and funding play a pivotal role in the growth of the Global Tissue Microarray Market Industry. Various health organizations and research institutions are increasingly investing in cancer research and personalized medicine, providing grants and funding opportunities for projects utilizing tissue microarrays. These initiatives not only enhance research capabilities but also promote collaboration between academia and industry, fostering innovation. The financial support from governments worldwide is likely to accelerate the adoption of tissue microarray technologies, contributing to the market's anticipated growth from 12.3 USD Billion in 2024 to 35.3 USD Billion by 2035, thereby reinforcing the industry's significance in advancing healthcare.

    Technological Advancements in Microarray Techniques

    Technological innovations significantly impact the Global Tissue Microarray Market Industry, as advancements in imaging and analysis techniques enhance the efficiency and accuracy of tissue microarray applications. Innovations such as automated slide scanning and high-throughput analysis allow researchers to process large volumes of samples with precision. These developments not only streamline workflows but also improve reproducibility in research findings. As a result, the industry is poised for growth, with the market expected to expand from 12.3 USD Billion in 2024 to 35.3 USD Billion by 2035. The integration of artificial intelligence in image analysis further indicates a transformative shift in how tissue microarrays are utilized in research and diagnostics.

    Increasing Prevalence of Cancer and Chronic Diseases

    The Global Tissue Microarray Market Industry is significantly influenced by the rising prevalence of cancer and chronic diseases worldwide. As the global burden of these diseases escalates, there is an increasing need for effective diagnostic tools that can facilitate early detection and treatment. Tissue microarrays enable researchers to analyze tumor heterogeneity and understand disease progression, which is vital for developing new therapeutic strategies. This growing demand for advanced diagnostic solutions is expected to contribute to the market's expansion, with projections indicating a growth from 12.3 USD Billion in 2024 to 35.3 USD Billion by 2035, reflecting a CAGR of 10.07% from 2025 to 2035.

    Growing Applications in Drug Development and Research

    The Global Tissue Microarray Market Industry is witnessing a surge in applications within drug development and research. Pharmaceutical companies increasingly utilize tissue microarrays to evaluate drug efficacy and safety profiles during preclinical studies. By analyzing the effects of new compounds on various tissue types, researchers can gain insights into potential therapeutic outcomes. This trend is expected to drive market growth, as the industry is projected to expand from 12.3 USD Billion in 2024 to 35.3 USD Billion by 2035. The ability to conduct high-throughput screening using tissue microarrays enhances the drug discovery process, making it a valuable tool for pharmaceutical research.

    Market Segment Insights

    Regional Insights

    Key Companies in the Tissue Microarray Market market include

    Industry Developments

      • In January 2017, Agilent technologies announced its collaboration with the Centre for Human Genetics of the University of Leuven and the University Hospital of Leuven in Belgium.
      • In July 2017, Horizon Discovery Group agreed to acquire GE Healthcare Dharmacon from parent General Electric for $85 million, creating a combined company focused on applying gene-editing and gene-modulation technologies in life science research.
      • In January 2017, Illumina Inc. announced the launch of a Single-Cell Sequencing Solution in collaboration with Bio-Rad. It is the first Next-Generation Sequencing (NGS) workflow for single-cell analysis providing researchers the ability to investigate the coordinated contribution of individual cells in tissue function, disease progression, and therapeutic response.

    Future Outlook

    Tissue Microarray Market Future Outlook

    The Global Tissue Microarray Market is projected to grow at a 10.07% CAGR from 2024 to 2035, driven by advancements in personalized medicine, increasing cancer research funding, and technological innovations in diagnostic tools.

    New opportunities lie in:

    • Develop novel tissue microarray platforms for high-throughput screening in drug discovery.
    • Leverage AI-driven analytics to enhance data interpretation and patient stratification.
    • Expand partnerships with biopharmaceutical companies for co-development of targeted therapies.

    By 2035, the market is expected to exhibit robust growth, positioning itself as a cornerstone in diagnostic and therapeutic advancements.

    Market Segmentation

    Report Overview

    Recent Developments
    • {"January 2017"=>[]}
    • {"July 2017"=>[]}
    • {"January 2017"=>[]}

    Market Segmentation

    By Region
    • {"Americas"=>[{"North America"=>["US", "Canada"]}]}
    • Latin America
    • {"Europe"=>[{"Western Europe"=>["Germany", "UK", "France", "Italy", "Spain", "Rest of Western Europe"]}]}
    • Eastern Europe
    • {"Asia-Pacific"=>["China", "Japan", "India", "Australia", "South Korea", "Rest of Asia-Pacific"]}
    • {"Middle East & Africa"=>["Middle East", "Africa"]}
    By End-user
    • Pharmaceutical and Biotechnological Companies
    • Research Organization
    By Procedure
    • Immunohistochemistry
    • Fluorescent in Situ Hybridization
    • Frozen Tissue Array
    By Technology
    • DNA Microarray
    • Polymerase Chain Reaction (PCR)
    • Next-Generation Sequencing
    • Northern Blotting
    • Western Blotting
    By Application
    • Oncology
    • Gene Expression Profiling
    • SNP Detection
    • Double-Stranded B-DNA Microarrays
    • Comparative Genomic Hybridization
    • Sequencing Bioinformatics

    Tissue Microarray Market Segmentation

    Major Key Players
    • Agilent Technologies
    • Illumina, Inc.
    • Asterand Bioscience
    •  Pantomics Inc.
    •  Applied Microarrays
    • Arrayit
    •  Phalanx Biotech
    • QIAGEN
    •  Takara Bio
    •  Perkin Elmer
    •  Merck Sharp & Dohme Corp.

    Report Scope

    Attribute/Metric Details
    Market Size 2023 11.18 (USD Billion)
    Market Size 2024 12.30 (USD Billion)
    Market Size 2032 26.47 (USD Billion)
    Compound Annual Growth Rate (CAGR) 10.11 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Agilent Technologies, Illumina, Inc., Protein Biotechnologies Inc., Asterand Bioscience, Pantomics Inc., Applied Microarrays, Arrayit, Phalanx Biotech, QIAGEN, Takara Bio, Perkin Elmer, and Merck Sharp & Dohme Corp.
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers ·  Increasing application in drug discovery ·  Increasing prevalence of cancer ·  Growing advancements in biotechnology and pharmaceutical companies ·  Rising demand for cost-effective and accurate diagnostic methods

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    [email protected]

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    [email protected]

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What would be the tissue microarray market valuation by 2032?

    The valuation would be USD 26.47 Billion by 2032.

    What is the predicted CAGR for the tissue microarray market during the forecast period (2024-2032)?

    tissue microarray market CAGR would be 10.11% during the forecast period (2024-2032).

    What are the major tissue microarray market drivers?

    Increasing the use of drug discovery, the prevalence of cancer, better inclusion of biotechnology and pharmaceutical companies, and effective use of cost-effective and accurate diagnostic methods are the major drivers.

    What was the research organization segment valuation in 2023?

    The valuation was USD 1876.02 million.

    Which region would lead the tissue microarray market?

    The Americas would enjoy the dominance in the tissue microarray market.

    1. '1 Report Prologue
    2. Market Introduction
      1. Introduction
    3. 18
    4. Scope Of Study 18
      1. Research Objective 18
      2. Assumptions & Limitations 19
        1. Assumptions 19
        2. Limitations
    5. 19
    6. Market Structure 20
    7. Research Methodology
      1. Research Process 21
      2. Market Size Estimation 23
        1. Market Share Analysis 23
      3. Forecast Model
    8. 25
    9. 4
    10. Market Dynamics
    11. Drivers 26
    12. Increasing Application In Drug Discovery 26
      1. Increasing Prevalence Of Cancer 26
        1. Increasing
    13. Advancements In Biotechnology And Pharmaceutical Companies 27
      1. Increasing Demand For Cost-Effective
    14. And Accurate Diagnostic Methods 28
      1. Restraints 28
        1. Tissue Microarray Is That It May Not Be Fruitful
    15. For Heterogeneous Cancers 28
      1. Opportunities 28
      2. Mega Trends 29
        1. Increasing Use Of Sequence Bioinformatics 29
      3. Macroeconomic
    16. Indicators 29
    17. Technology Trends & Assessment 30
    18. Market Factor Analysis
      1. Porter’s Five Forces
    19. Model 31
    20. Bargaining Power Of Suppliers 31
      1. Bargaining Power Of Buyers 31
        1. Threat Of New Entrants
    21. 32
    22. Threat Of Substitutes 32
      1. Intensity Of Rivalry 32
      2. Value Chain Analysis 33
        1. R&D 33
        2. Clinical Test &
    23. Legal Issues 33
    24. Patenting & Manufacturing 34
      1. Marketing & Sales 34
      2. Pricing Analysis 34
      3. Investment Opportunity Analysis 35
      4. Merger &
    25. Acquisition Landscape 35
    26. Tissue Microarray Market, By Procedure
      1. Introduction 37
      2. Immunohistochemistry 38
      3. Fluorescent In Situ Hybridization
    27. 39
    28. Frozen Tissue Array 40
    29. Tissue Microarray Market, By Technology
      1. Introduction 41
      2. DNA Microarray 43
      3. Polymerase Chain Reaction (PCR) 44
      4. Next-Generation
    30. Sequencing 45
    31. Northern Blotting 46
      1. Western Blotting 47
    32. Tissue Microarray Market, By Application
      1. Introduction
    33. 48
    34. Oncology 49
    35. Gene Expression Profiling 50
      1. SNP Detection 51
      2. Double-Stranded B-DNA Microarrays 52
      3. Comparative
    36. Genomic Hybridization 53
      1. Sequencing Bioinformatics 54
    37. Tissue Microarray Market, By End User
      1. Introduction
    38. 55
    39. Pharmaceutical And Biotechnological Companies 56
      1. Research Organization 57
    40. Global Tissue Microarray Market,
    41. By Region
    42. Introduction 58
    43. Americas 60
    44. Tissue
    45. Microarray Market, By Procedure
    46. Tissue Microarray Market, By Technology
    47. Tissue Microarray Market,
    48. By Application
    49. Microarray Market, By End User
      1. U.S. 64
    50. Tissue Microarray Market, By Procedure
    51. Tissue Microarray
    52. Market, By Technology
    53. Tissue Microarray Market, By Application
    54. Tissue Microarray Market, By End User
      1. Canada 67
    55. Market, By Procedure
    56. Market, By End User
      1. South America 70
      2. Europe 74
        1. Germany 78
    57. Tissue Microarray Market, By
    58. Technology
    59. Microarray Market, By Application
      1. France 81
    60. By Procedure
    61. Microarray Market, By Technology
    62. By End User
    63. UK 84
      1. Italy 87
        1. Spain 90
        2. Rest Of Western Europe 93
        3. Eastern Europe
    64. 96
      1. Asia Pacific 100
        1. Japan 104
        2. China 107
        3. India 110
    65. Australia 113
      1. Republic Of Korea 116
        1. Rest Of Asia Pacific
    66. 119
      1. Middle East & Africa 123
    67. Procedure
    68. UAE 127
      1. Saudi Arabia 130
        1. Oman 133
        2. Kuwait 136
        3. Qatar 139
    69. Rest Of Middle East & Africa 142
    70. Competitive Landscape
      1. Introduction
    71. 146
    72. Company Share Analysis 146
    73. Company Profile
      1. Agilent Technologies 147
        1. Company Overview 147
        2. Product/Business Segment
    74. Overview 147
    75. Financial Overview 148
      1. Key Development 149
        1. SWOT Analysis 150
      2. Applied Microarrays 151
        1. Overview
    76. 151
    77. Product/Business Segment Overview 151
      1. Financial Overview 151
        1. Key Development 151
        2. SWOT Analysis
    78. Arrayit 153
    79. Overview 153
    80. Product/Business Segment Overview 153
      1. Financial Overview 153
        1. SWOT Analysis 154
      2. Asterand Bioscience
    81. 155
    82. Company Overview 155
      1. Product/Business Segment Overview 155
        1. Financial Overview 155
        2. Key Developments
    83. SWOT Analysis 156
      1. Horizon Discovery 157
        1. Overview 157
        2. Product/Business Segment Overview 157
        3. Financial
    84. Overview 157
    85. Key Development 158
      1. SWOT Analysis 159
      2. Illumina Inc. 160
        1. Company Overview 160
        2. Product/Business Segment
    86. Overview 160
    87. Financial Overview 161
      1. Key Development 162
        1. SWOT Analysis 163
      2. Protein Biotechnologies
    88. Inc. 164
    89. Company Overview 164
      1. Product/Business Segment Overview 164
        1. Financial Overview 165
        2. Key Development
    90. 165
    91. SWOT Analysis 165
      1. Pantomics Inc. 166
        1. Company Overview 166
        2. Product/Business Segment
    92. Overview 166
    93. Financial Overview 166
      1. Key Development 166
        1. SWOT Analysis 167
      2. Phalanx Biotech Group 168
        1. Overview
    94. 168
    95. Product/Business Segment Overview 168
      1. Financial Overview 168
        1. Key Development 168
        2. SWOT Analysis
    96. 169
    97. Perkin Elmer 170
    98. Overview 170
    99. Product/Business Segment Overview 170
      1. Financial Overview 170
        1. Key Development 171
        2. SWOT Analysis
    100. 172
    101. QIAGEN 173
    102. Company Overview 173
      1. Product/Business Segment Overview 173
        1. Financial Overview 173
        2. Key Development
    103. 174
    104. SWOT Analysis 175
      1. SeraCare 176
        1. Overview 176
        2. Product/Business Segment Overview 176
        3. Financial
    105. Overview 176
    106. Key Development 177
      1. SWOT Analysis 177
      2. Takara Bio Inc. 178
        1. Company Overview 178
        2. Product/Business
    107. Segment Overview 178
      1. Financial Overview 179
        1. Key Development 180
        2. SWOT Analysis 180
    108. MRFR Conclusion
      1. Key Findings
    109. 182
    110. From CEO’s View Point 182
      1. Unmet Needs 182
      2. Key Companies To Watch 182
    111.  
    112. List Of Tables
    113. TABLE 1 MERGER AND ACQUISITION
    114. LANDSCAPE 35
    115. TABLE
    116. GLOBAL TISSUE MICROARRAY MARKET, BY PROCEDURE, 2020-2027 (USD MILLION) 37
    117. TABLE 3 GLOBAL
    118. TISSUE MICROARRAY MARKET FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2020-2027 (USD MILLION)
    119. 38
    120. GLOBAL TISSUE MICROARRAY MARKET FOR FLUORESCENT IN SITU HYBRIDIZATION, BY REGION,
    121. 2027 (USD MILLION) 39
    122. TABLE 5 GLOBAL TISSUE MICROARRAY MARKET FOR FROZEN TISSUE ARRAY, BY
    123. REGION, 2020-2027 (USD MILLION) 40
    124. TABLE 6 GLOBAL TISSUE MICROARRAY MARKET, BY TECHNOLOGY,
    125. 2027 (USD MILLION) 41
    126. TABLE 7 GLOBAL TISSUE MICROARRAY MARKET FOR DNA MICROARRAY, BY REGION,
    127. 2027 (USD MILLION) 43
    128. TABLE 8 GLOBAL TISSUE MICROARRAY MARKET FOR POLYMERASE CHAIN REACTION
    129. (PCR), BY REGION, 2020-2027 (USD MILLION) 44
    130. TABLE 9 GLOBAL TISSUE MICROARRAY MARKET FOR NEXT-GENERATION
    131. SEQUENCING, BY REGION, 2020-2027 (USD MILLION) 45
    132. TABLE 10 GLOBAL TISSUE MICROARRAY MARKET FOR NORTHERN
    133. BLOTTING, BY REGION, 2020-2027 (USD MILLION) 46
    134. TABLE 11 GLOBAL TISSUE MICROARRAY MARKET FOR WESTERN
    135. BLOTTING, BY REGION, 2020-2027 (USD MILLION) 47

    Tissue Microarray Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027